Meningitis Vaccine Side Effects: What to Expect and When to Get Help

Reading time: 9 minutes
Reading mode:

Meningitis vaccine side effects at a glance

Most people who receive a meningococcal vaccine have no problems beyond mild, short-lived reactions. When side effects do occur, they typically involve soreness where the shot was given, along with general symptoms like tiredness, headache, or muscle aches. These reactions reflect the immune system responding to the vaccine and usually resolve on their own within a few days.

What counts as a “typical” reaction, and how long it lasts, depends partly on which vaccine was given. Meningococcal vaccines fall into different categories, commonly referred to as MenACWY, MenB, and MenABCWY, and their side-effect profiles are not identical. MenACWY vaccination tends to produce a shorter reaction window, while MenB and MenABCWY vaccines are associated with a broader range of possible systemic symptoms, including fever, nausea, or diarrhea, and reactions that may take longer to fade.

Have you ever experienced side effects after a meningococcal vaccine?

Think of side effects in two tiers. The first tier includes expected, self-limited symptoms like injection-site redness or fatigue, the kind that generally do not need medical attention. The second tier includes rare but urgent symptoms, such as signs of a severe allergic reaction or fainting near the time of vaccination, which call for immediate attention. Break down what to expect from each vaccine type, how long symptoms usually last, and how to recognize when something falls outside the ordinary pattern.

MenACWY, MenB, and MenABCWY: why vaccine type matters

“Meningitis vaccine” is a convenient shorthand, but it glosses over real differences between products. In US terminology, these vaccines are grouped by which meningococcal bacterial serogroups they target. MenACWY vaccines protect against serogroups A, C, W, and Y. MenB vaccines protect against serogroup B, a distinct target that MenACWY vaccines do not cover. MenABCWY vaccines are newer combination products designed to cover all five of these serogroups, A, B, C, W, and Y, in a single vaccine.

Close-up of a meningococcal vaccine being administered into the upper arm

For understanding side effects because these are not simply different brand names for the same formulation. They contain different antigens and are built on different vaccine technologies, which is part of why their reaction profiles differ, a point covered in the next section.

Because of this variation, it is worth checking which specific vaccine was administered rather than assuming that information about one meningococcal vaccine applies to all of them. The Vaccine Information Statement provided at the time of vaccination identifies the exact product given and lists the reactions relevant to that vaccine. Matching side-effect expectations to the actual product, rather than to the general category of “meningitis vaccine,” gives a more accurate picture of what to watch for and helps avoid confusion if symptoms arise that do not match what was expected.

Which type of meningococcal vaccine have you received?
Take a quick knowledge check. Select one answer for each question and discover how familiar you are with the subject.

Meningococcal vaccine side effects and safety

How long do side effects usually last after receiving a MenB or MenABCWY meningococcal vaccine, when they occur?

Common side effects by vaccine type

Reactions after meningococcal vaccination differ somewhat depending on whether a MenACWY vaccine or a MenB/MenABCWY vaccine was given, so it helps to separate the two.

After MenACWY vaccination, commonly reported effects include:

  • Redness or soreness at the injection site
  • Muscle pain
  • Headache
  • Tiredness

After MenB or MenABCWY vaccination, the range of possible reactions tends to be broader, and can include:

  • Redness, soreness, or swelling at the injection site
  • Tiredness
  • Headache
  • Muscle or joint pain
  • Fever or chills
  • Nausea
  • Diarrhea

The overlap between the two lists, injection-site discomfort, fatigue, headache, and muscle pain, reflects reactions common across many vaccines as the immune system responds. The additional symptoms sometimes seen with MenB and MenABCWY vaccines, such as fever, chills, or gastrointestinal upset, are more systemic in nature.

These are lists of possible reactions rather than predictions for any individual. Not everyone experiences these effects, and having none of them does not mean the vaccine failed to prompt an immune response. Because different studies and products are not directly comparable, it is not meaningful to rank exactly how often one vaccine causes a particular symptom versus another; the practical takeaway is simply which symptoms belong to which category.

How long meningitis vaccine side effects last

When reactions do occur, their expected duration also differs by vaccine category. After MenACWY vaccination, side effects usually last one to two days. After MenB or MenABCWY vaccination, side effects usually last three to five days when they occur.

These figures describe typical patterns, not fixed rules. Some people notice symptoms resolving sooner, while others may find mild soreness or tiredness lingering a bit past the usual window. If symptoms are clearly worsening rather than gradually improving, or if they persist well beyond these general timeframes, that is a reasonable prompt to check in with a healthcare professional rather than assuming it will pass.

If you experienced side effects from a meningococcal vaccine, how long did they last?

Being clear about what this duration does and does not tell you. How long a side effect lasts has nothing to do with how long the vaccine's protection lasts. A reaction fading after a couple of days does not mean immune protection is also fading on that timeline, and a longer-lasting reaction does not indicate stronger or longer protection. Side-effect duration reflects how the body processes the vaccine in the short term; protection against meningococcal disease is a separate, longer-term immune process that this article does not cover in detail.

Fainting, allergic reactions, and other concerning symptoms

Two categories of uncommon events deserve special attention because they can look alarming but require different responses.

Person applying a cool damp cloth to their upper arm to ease injection site soreness

Fainting can happen after many kinds of medical procedures, including vaccination, and it is not unique to meningococcal vaccines. Because a fall during fainting can cause injury, vaccination is generally given while the person is seated or lying down, and staying seated or lying down for a period afterward can reduce the chance of injury if fainting does occur. Anyone who faints after vaccination should be watched until the symptoms fully resolve.

A severe allergic reaction is different from fainting and is a medical emergency. Warning signs include hives, swelling of the face or throat, difficulty breathing, a fast heartbeat, dizziness, or weakness. If any of these appear after a meningococcal vaccine, the appropriate response is to call 911 immediately rather than waiting to see if symptoms pass on their own.

Guillain-Barré syndrome (GBS) is sometimes raised in discussions of vaccine safety. Being precise here: health authorities that guide US vaccination practice no longer consider a history of GBS a reason to avoid or delay meningococcal vaccination. Earlier research involving an older meningococcal vaccine found that if any GBS risk existed, it was small, and this does not establish that current meningococcal vaccines cause GBS. Reports of GBS occurring sometime after vaccination do not, by themselves, prove that the vaccine was the cause.

Managing mild side effects after vaccination

Ordinary injection-site soreness, redness, or swelling can often be eased with simple, conservative measures rather than anything elaborate. Applying a cool, damp cloth to the area is a straightforward way to ease discomfort while the reaction resolves on its own over the following days.

For pain or fever more broadly, especially in children, the more cautious approach is to ask the child's healthcare professional whether a non-aspirin pain reliever is appropriate, rather than choosing a medication or dose independently. A clinician or pharmacist can factor in age, weight, and any other health conditions before recommending anything, which is not something this kind of general guidance can safely substitute for.

These comfort measures apply specifically to mild, expected reactions, things like soreness, low-grade fatigue, or a mild headache. They are not appropriate substitutes for medical attention if symptoms look more like a severe allergic reaction or otherwise fall outside what would be considered a routine, self-limited response. Knowing the difference, covered in the previous section, is what determines whether home comfort measures are the right next step or whether it is time to seek help instead.

Precautions to discuss before another dose

Before receiving another meningococcal vaccine dose, certain history is worth flagging to the provider ahead of time rather than mentioning it only after a problem arises.

Anyone who has had a life-threatening reaction after a previous meningococcal vaccine, or who has a life-threatening allergy to a component of the vaccine, should tell the vaccination provider about this before proceeding. This information helps the provider determine whether it is appropriate to move forward, and how to do so safely if they do.

A separate, common question is whether being mildly sick, such as having a cold, should delay vaccination. Vaccination during a mild illness is considered acceptable. The provider is in the best position to judge whether a person's particular symptoms warrant postponing the dose, since illness severity and individual circumstances can vary. Rather than trying to decide this alone, it is reasonable to mention how you are feeling that day and let the provider weigh in.

Beyond these two points, this is not the place to try to self-diagnose contraindications or guess at how allergy history might interact with a specific vaccine formulation. That kind of individualized assessment belongs with the vaccination provider, who has access to the full clinical picture and the specific product being considered.

When to contact a healthcare professional or report a reaction

Three distinct actions are worth keeping separate, since each serves a different purpose.

Call 911 or seek emergency care right away if you notice signs of a severe allergic reaction, such as hives, swelling of the face or throat, difficulty breathing, a fast heartbeat, dizziness, or weakness. These symptoms can escalate quickly and should not wait for a scheduled appointment.

Contact a healthcare professional, on a less urgent basis, if side effects are not following the expected pattern. This includes reactions lasting noticeably longer than the usual one to two days for MenACWY or three to five days for MenB and MenABCWY, or symptoms that seem to be getting worse rather than gradually easing. A clinician can assess whether what you are experiencing fits the expected picture or needs a closer look.

In the United States, patients and caregivers have the option to report concerning health events after vaccination to the Vaccine Adverse Event Reporting System, VAERS, even if they are not certain the vaccine was responsible. Submitting a report is a way of documenting that an event occurred after vaccination; it does not, on its own, prove that the vaccine caused it. This reporting option is specific to the US system and does not necessarily apply the same way in other countries. Reporting is a complement to, not a substitute for, getting medical attention when symptoms warrant it.

Meningococcal Vaccine Safety

Publishing organization: Centers for Disease Control and Prevention

Meningococcal ACWY Vaccine Information Statement

Publishing organization: Centers for Disease Control and Prevention

Meningococcal B Vaccine Information Statement

Publishing organization: Centers for Disease Control and Prevention

Questions and comments

Question from a reader

If I had a severe allergic reaction to one meningitis vaccine, can I receive a different meningitis vaccine later?

Response from the editor

You should tell your provider about the reaction; they can evaluate whether another meningococcal vaccine is safe for you based on the type of reaction and vaccine components. The decision is made by your healthcare professional.

Please do not include passwords, medical record numbers, insurance information, financial information, precise addresses, or other confidential or directly identifying information in your message.